FDA Inspection 1330360 — Mark R. Stein, M.D.
The FDA completed an inspection of Mark R. Stein, M.D. on Jun 17, 2026 in North Palm Beach, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 17, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- North Palm Beach, FL (United States)
Additional Details
Clinical Investigator (CI)